The Global Neurology Academy (GNA) series offers certified education modules and video interviews from leading MS experts from across the globe as they address topics such as induction therapy in relapsing-remitting multiple sclerosis; No Evidence of Disease Activity (NEDA) concept; how different agents used in MS management may be utilized in induction therapy; appreciation of how reductions in end-organ damage impact patient quality-of-life; mechanisms of action of the classical as well as emergent agents; key issues associated with making the correct differential diagnosis of multiple sclerosis, in addition to how best to incorporate prognostic indicators into clinical decision-making; current and emergent novel oral agents in MS management; and diagnostic strategies and identifying predictors of outcome.
For more information about GNA, visit www.globalneurologyacademy.org.
Mind Matters: Psychiatric Comorbidity in the Prodromal Phase of MS
Mind Matters: Psychiatric Comorbidity in the Prodromal Phase of MS
Cases in TK2d Care: Lessons Learned in Diagnosing and Managing a Rare Disease
Cases in TK2d Care: Lessons Learned in Diagnosing and Managing a Rare Disease
Improving the Early Detection of TK2d with Genetic Testing
Improving the Early Detection of TK2d with Genetic Testing
Mitochondrial Matters: A Clinician’s Insights on Thymidine Kinase 2 Deficiency
Mitochondrial Matters: A Clinician’s Insights on Thymidine Kinase 2 Deficiency
Diagnosing Suspected MS: A Review of the Updated Guidelines
Diagnosing Suspected MS: A Review of the Updated Guidelines
Understanding the Fine Print: The Who, When, And What To Do About ARIA in Patients with Alzheimer’s Disease – Neurology Module
Understanding the Fine Print: The Who, When, And What To Do About ARIA in Patients with Alzheimer’s Disease – Neurology Module
The Future of Muscular Dystrophy Management: Updates for Limb Girdle Muscular Dystrophy
The Future of Muscular Dystrophy Management: Updates for Limb Girdle Muscular Dystrophy
The Future of Muscular Dystrophy Management: Updates for Duchenne Muscular Dystrophy
The Future of Muscular Dystrophy Management: Updates for Duchenne Muscular Dystrophy
Quarterbacking the Interprofessional Team: Optimizing Collaboration and Communication To Enhance Patient Outcome
Quarterbacking the Interprofessional Team: Optimizing Collaboration and Communication To Enhance Patient Outcome
Novel Investigational Treatment Options for Rett Syndrome
Novel Investigational Treatment Options for Rett Syndrome
Case Study: Relatively Late Diagnosis & Management of Rett Syndrome
Case Study: Relatively Late Diagnosis & Management of Rett Syndrome
New Hope: Novel and Emerging Treatment Options for Rett Syndrome
New Hope: Novel and Emerging Treatment Options for Rett Syndrome
Compassionate Communication: Keeping the Patient and Family Informed Throughout the Patient’s Journey Through the Four Stages With Rett Syndrome
Compassionate Communication: Keeping the Patient and Family Informed Throughout the Patient’s Journey Through the Four Stages With Rett Syndrome
Recognizing the Early and Subtle Signs and Symptoms of Rett Syndrome
Recognizing the Early and Subtle Signs and Symptoms of Rett Syndrome